2006 Annual Meeting | Parkinson's Disease Therapy

Date Friday 04/07/06

Time 07:00 PM - 09:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Therapy Program

Director(s) Oksana Suchowersky, MD, FAAN

Topic(s)

Learning Objectives Upon Completion:
Participants should be familiar with pharmaceutical, surgical, and alternative treatment options for patients with Parkinson's disease and understand the rationale for choosing different treatment strategies in different stages of disease.

CME Available No CME available

Core Competencies Medical Knowledge

Program Level Advanced

Recommended Audience Practitioner, Fellow, Resident, Nurse

Event Timeline
07:00 PM - 07:40 PM		Treatment of Patients With Early Disease Oksana Suchowersky, MD, FAAN
07:00 PM - 09:00 PM		Refreshments
07:40 PM - 08:20 PM		Treatment of Patients With Advanced Disease Stewart A. Factor, DO, FAAN
08:20 PM - 08:45 PM		Case Studies Discussion
08:45 PM - 09:00 PM		Questions and Answers

Faculty Disclosures
Stewart A. Factor, DO, FAAN	Dr. Factor has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. Dr. Factor has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Factor has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. The institution of Dr. Factor has received research support from Biohaven. The institution of Dr. Factor has received research support from Voyager. The institution of Dr. Factor has received research support from Neurocrine. The institution of Dr. Factor has received research support from Supernus. The institution of Dr. Factor has received research support from Prelinia. The institution of Dr. Factor has received research support from Medtronics. The institution of Dr. Factor has received research support from Boston Scientific. The institution of Dr. Factor has received research support from Sun Pharmaceuticals Advanced Research Company. The institution of Dr. Factor has received research support from Aspen. Dr. Factor has received publishing royalties from a publication relating to health care. Dr. Factor has received publishing royalties from a publication relating to health care. Dr. Factor has received publishing royalties from a publication relating to health care. Dr. Factor has received publishing royalties from a publication relating to health care.
Oksana Suchowersky, MD, FAAN	Dr. Suchowersky has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Syneos/Alexion. The institution of Dr. Suchowersky has received research support from Roche. The institution of Dr. Suchowersky has received research support from Wave LifeSciences. The institution of Dr. Suchowersky has received research support from CHDI. Dr. Suchowersky has received publishing royalties from a publication relating to health care. Dr. Suchowersky has received publishing royalties from a publication relating to health care.

��ɫ��

��ɫ��